Technology Landscape of Drug Portfolio Analysis

Regulatory filings: All upcoming requests &amp; approvals in various geographies where the client operates: Asia, Middle East &amp; Africa (AMEA) Europe Latin America North America
Regulatory trends: Product segment-wise Technology-wise Others

The objective of study was to analyze the pattern and compare portfolio of drugs in pipeline to those being translated to FDA approval stage.

Key drivers and challenges were also identified with respect to drugs in various therapeutic domains along with unmet medical needs.